15% OFF YOUR FIRST ORDER · CODE 1stOrder
Research hub

DSIP Peptide

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide studied in sleep biology, neurobiology, and neuroendocrine research. Direct SARMs supplies DSIP exclusively for laboratory research. Please browse the available products below.

DSIPSynthetic Peptide9 Amino AcidsLinear Structure
Molecular Weight
848.81 g/mol
Molecular Formula
C35H48N10O15
CAS Number
62568-57-4
Purity
99.5%
Available nowDSIP Peptide · in stock, EU dispatch
DSIP Nasal Spray
15ml and 30ml
Price range: $82.50 through $158.57View
DSIP Peptide Vial
2mg, 5mg, 10mg
Price range: $22.76 through $87.15View
DSIP Pre Mixed Peptide
5mg
Price range: $41.16 through $117.06View
Epithalon DSIP Nasal Stack
Price range: $109.69 through $206.70View
Epithalon DSIP Vial Stack
2 mg
$39.95View
01

What Is DSIP Peptide?

DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide consisting of nine amino acid residues. Researchers identified its sequence as Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE) through amino acid analysis and sequence determination.

The original studies isolated DSIP from rabbit cerebral venous blood and established its chemical structure through characterization and synthesis. DSIP belongs to the oligopeptide class.

02

Research Overview Table

Research OverviewCurrent Status
Compound ClassEndogenous nonapeptide/neuropeptide
Primary Research TargetSleep-related neurophysiological and neuroendocrine pathways
Published Cell StudiesAvailable
Published Animal StudiesAvailable
Controlled Human Clinical TrialsPublished controlled human studies available
Primary Research FieldSleep biology, neurobiology, and neuroendocrine research
Research MaturityPredominantly preclinical, with a limited body of human research
Intended UseLaboratory research only
03

Chemical and Molecular Characteristics

Chemical NameDelta Sleep-Inducing Peptide (DSIP)
Compound NameDSIP (Delta Sleep-Inducing Peptide)
Compound TypeNonapeptide
Molecular FormulaC35H48N10O15
Molecular Weight848.81 g/mol
Purity99.5%
CAS Number62568-57-4
Batch/Lot Number20250916033
Primary Research TargetSleep-related neurophysiological and neuroendocrine pathways
Product Format(s)Lyophilized vials, nasal sprays, or pre-mixed injection pen
Physical PresentationSupplied as sterile lyophilized powder or pre-formulated liquid, depending on the selected product format

DSIP has the molecular formula C35H48N10O15 and a molecular weight of 848.81 g/mol. Its sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE). The peptide contains acidic and polar residues within its nine-residue structure.

Structural studies describe DSIP as a charged, hydrophilic peptide with conformational flexibility in solution. Spectroscopic analyses found a dynamic equilibrium between unordered and folded structures. Residues 2–5 and 6–9 tend to form type I β-turns in aqueous solution, while a more ordered, helix-like structure occurs in 40% trifluoroethanol.

Certificates:

CoAhttps://lithuania.direct-sarms.com/wp-content/uploads/2026/09/DSIP_COA.pdf
HPLChttps://lithuania.direct-sarms.com/wp-content/uploads/2026/09/DSIP_HPLC.pdf
04

Mechanism of Action Under Investigation

Published studies have investigated DSIP in relation to adrenergic signaling. In rat pineal tissue, DSIP altered norepinephrine-stimulated N-acetyltransferase (NAT) activity. Prazosin eliminated the DSIP-associated enhancement, while propranolol reduced the norepinephrine response. The investigators concluded that DSIP modulated the α₁-adrenergic receptor response to adrenergic stimulation.

A separate study examined dopaminergic signaling in the rat hypothalamic median eminence. DSIP inhibited somatostatin (SRIF) release in an in vitro preparation, and pimozide blocked this effect. The investigators concluded that DSIP inhibited SRIF release through a dopaminergic mechanism.

Researchers also investigated DSIP in relation to opioid signaling. DSIP did not show binding activity at the opioid receptor subtypes tested. However, it stimulated calcium-dependent release of immunoreactive Met-enkephalin from rat lower-brainstem slices. The findings supported an indirect interaction with opioid signaling rather than direct opioid-receptor binding.

The literature therefore contains experimental evidence for DSIP-related modulation of adrenergic, dopaminergic, and opioid-associated signaling, but these studies do not establish a single receptor-mediated mechanism for the peptide. A review of the literature likewise described the proposed mechanisms as requiring further establishment.

05

Scientific Research Context

DSIP has a long history in the scientific literature, beginning with early investigations of the peptide and continuing through later experimental studies. The research base includes in vitro work and preclinical animal studies, with a smaller body of human research. Overall, the literature represents an experimental evidence base rather than a mature clinical research field. Studies have appeared across different periods and used several experimental systems to examine the peptide. Current evidence therefore remains weighted toward laboratory and preclinical research, with human evidence forming a more limited part of the overall literature.

06

DSIP Biology and Biological Pathways

01

Primary Biological Function

DSIP research has focused mainly on sleep–wake regulation and circadian biology. Researchers examine these systems because DSIP-related material has been identified in the brain and peripheral tissues, and studies have measured its relationship with sleep and daily physiological rhythms.

02

Relevant Metabolic or Signaling Pathways

The main biological pathways investigated include circadian regulation and neuroendocrine signaling. Researchers examine these pathways because sleep and endocrine activity change across the daily cycle. Studies have therefore examined DSIP alongside hormonal variables, including cortisol and growth hormone.

03

Tissue-Specific Biology

Researchers have identified DSIP-like immunoreactivity in the hypothalamus and pituitary, including the arcuate nucleus, median eminence, and pituitary stalk. These regions are relevant because they form important parts of the neuroendocrine system. Human studies have also examined DSIP-related material in the pituitary.

04

Experimental Biomarkers

Common biological measurements in DSIP research include EEG activity, sleep-stage measures, plasma DSIP-like immunoreactivity, cortisol, and growth hormone. Researchers use these measures to examine relationships between DSIP related measurements, sleep physiology, circadian timing, and endocrine activity.

05

Laboratory Investigation Methods

Published DSIP studies have used electroencephalography, radioimmunoassay, immunohistochemistry, and immunofluorescence. These methods allow researchers to measure electrical activity and detect DSIP-like immunoreactivity in biological tissues and fluids.

07

Experimental Models Used in Published Research

Published DSIP research has used several experimental models to examine the peptide under controlled conditions. These include rabbits, rats, cats, and guinea pigs, as well as isolated or perfused tissue preparations. The models differ in their experimental purpose, measurements, and physiological scope. Their main limitations include species differences and the reduced physiological complexity of isolated preparations.

01

Rabbit Models

Freely moving rabbits have been used for DSIP studies involving EEG and motor-activity recording. The model allows continuous measurement of cortical electrical activity alongside behavioral activity in an intact animal. Rabbit models are also represented in the original chemical characterization work. Their main limitation is species-specific physiology, which limits direct comparison with humans.

02

Rat Models

Adult male Wistar rats were used in DSIP experiments involving continuous EEG recording and power-spectrum analysis. The model provided repeated EEG measurements over defined experimental periods. Published DSIP research also used Wistar rats in audiogenic seizure experiments with EEG recording. A limitation is that these are species-specific animal models and do not reproduce the full complexity of human physiology.

03

Cat Models

Cats have been used in controlled sleep studies with polygraphic recording of EEG, electrooculography, and electromyography. This model allows separate characterization of sleep and wake states during prolonged recording periods. Its principal limitation is species-specific sleep architecture, which can produce responses that do not directly correspond to human sleep physiology.

04

Guinea Pig Perfused-Brain Models

The in situ vascularly perfused guinea-pig forebrain provides a controlled model for studying DSIP at the blood–brain barrier. The preparation permits measurement of peptide uptake across the brain capillary interface. Its main limitation is that the perfused preparation does not reproduce the full physiological conditions of an intact animal.

08

DSIP Published Research

01

Sleep and Sleep Architecture

Published research has investigated DSIP in relation to sleep initiation, sleep architecture, sleep stages, and EEG activity. Studies have also examined changes in sleep-related EEG measures and the timing of DSIP-like immunoreactivity in relation to sleep onset.

02

Circadian and Locomotor Activity

DSIP research has examined circadian rhythmicity and locomotor activity, including daily activity patterns under normal light–dark cycles and continuous illumination. Studies also examined whether DSIP-related changes in locomotor activity varied across different phases of the circadian cycle.

03

Neuroendocrine Research

Studies have investigated DSIP in relation to ACTH, cortisol, growth-hormone, prolactin, and somatostatin secretion. Research has examined ACTH and cortisol responses to CRH and other physiological stimuli, growth hormone and prolactin secretion, and somatostatin release from hypothalamic tissue.

04

Tissue Distribution

Researchers have investigated the distribution of DSIP and DSIP-like immunoreactive material in the brain, pituitary, peripheral organs, plasma, cerebrospinal fluid, and other tissues. Immunohistochemical and radioimmunochemical studies have been used to characterize this distribution.

05

Blood–Brain and Blood–CSF Transport

Research has examined DSIP penetration of the blood–brain and blood–cerebrospinal fluid barriers, including peptide uptake, permeability, and transport kinetics. Studies have also examined DSIP analogs to compare their penetration and the influence of structural and physicochemical properties on barrier transport.

06

Neurotransmitter and Neuropharmacological Research

Research has examined DSIP in relation to serotonin, dopamine, and norepinephrine, as well as its interaction with selected neuropharmacological agents. Investigations have also examined possible serotonergic involvement and DSIP-related changes in brain monoamine concentrations.

09

Analytical Documentation

HPLC separates DSIP from related substances and assesses peptide purity. LC-MS provides molecular-mass data to support peptide identity. NMR provides additional structural information about the peptide. A Certificate of Analysis (COA) documents batch-specific identity, purity, and other analytical results.

Analytical verification helps confirm the identity and quality of material used in laboratory research. Analytical documentation verifies product identity and quality, not biological performance.

10

Storage and Laboratory Handling

Store DSIP at 2–8°C, as specified in the product specification. Keep the vial properly sealed during storage and protect the material from contamination.

Handle DSIP in a suitable laboratory environment with appropriate precautions to maintain material integrity. Qualified laboratory personnel should handle the peptide using clean procedures and equipment to reduce the risk of contamination. Keep the batch information and analytical documentation with the material during laboratory use.

DSIP is supplied exclusively for laboratory research and should remain within qualified laboratory settings.

11

Frequently asked questions

DSIP (delta sleep-inducing peptide) is a nonapeptide, meaning it contains nine amino acids. Its sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE). It belongs to the oligopeptide class.
12

Why choose us?

Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.

Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.

Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.

DSIP Peptide is supplied solely for laboratory research and analytical purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or any clinical application. Information provided on this page is for scientific reference only and should be considered alongside the cited primary literature and relevant analytical documentation.
Available now

DSIP Peptide from Direct Sarms Lithuania

DSIP Nasal Spray
15ml and 30ml
Price range: $82.50 through $158.57View
DSIP Peptide Vial
2mg, 5mg, 10mg
Price range: $22.76 through $87.15View
DSIP Pre Mixed Peptide
5mg
Price range: $41.16 through $117.06View
Epithalon DSIP Nasal Stack
Price range: $109.69 through $206.70View